U.S. Markets closed

Top Ranked Momentum Stocks to Buy for November 11th

Zacks Equity Research

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 11th:

Fulgent Genetics, Inc. (FLGT): This genetic testing services provider has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 80% over the last 60 days.

FULGENT GENETIC Price and Consensus

FULGENT GENETIC Price and Consensus

FULGENT GENETIC price-consensus-chart | FULGENT GENETIC Quote

Fulgent Genetics’ shares gained 43.4% over the last one month more than S&P 500’s gain of 4.4%. The company possesses a Momentum Score of A.

FULGENT GENETIC Price

FULGENT GENETIC Price

FULGENT GENETIC price | FULGENT GENETIC Quote

Luna Innovations Incorporated (LUNA): This manufacturer of fiber optic sensing, and test and measurement products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.8% over the last 60 days.

Luna Innovations Incorporated Price and Consensus

Luna Innovations Incorporated Price and Consensus

Luna Innovations Incorporated price-consensus-chart | Luna Innovations Incorporated Quote

Luna Innovations’s shares gained 18.2% over the last one month. The company possesses a Momentum Score of A.

Luna Innovations Incorporated Price

Luna Innovations Incorporated Price

Luna Innovations Incorporated price | Luna Innovations Incorporated Quote

Intra-Cellular Therapies, Inc. (ITCI): This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.9% over the last 60 days.

Intra-Cellular Therapies Inc. Price and Consensus

Intra-Cellular Therapies Inc. Price and Consensus

Intra-Cellular Therapies Inc. price-consensus-chart | Intra-Cellular Therapies Inc. Quote

Intra-Cellular Therapies’ shares gained 23.1% over the last one month. The company possesses a Momentum Score of A.

Intra-Cellular Therapies Inc. Price

Intra-Cellular Therapies Inc. Price

Intra-Cellular Therapies Inc. price | Intra-Cellular Therapies Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Luna Innovations Incorporated (LUNA) : Free Stock Analysis Report
 
Intra-Cellular Therapies Inc. (ITCI) : Free Stock Analysis Report
 
FULGENT GENETIC (FLGT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research